Emergent BioSolutions (EBS) Reports Q1 Loss of $3.17
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.62 +2.67%
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
(Updated - May 9, 2023 5:00 PM EDT)
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of ($3.17), versus $0.00 reported last year. Revenue for the quarter came in at $165.1 million versus the consensus estimate of $175.12 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions
- Marvell (MRVL) PT Raised to $225 at TD Cowen
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
